BIOMARIN PHARMACEUTICALS has a total of 14 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are REESE RES FOUND, APTEVO BIOTHERAPEUTICS LLC and THROMB X NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 5 | |
#3 | United States | 2 | |
#4 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Enzymes | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Unspecified technologies | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Klock John C | 10 |
#2 | Starr Christopher M | 8 |
#3 | Mishra Chittra | 4 |
#4 | Chen Lin | 2 |
#5 | Fitzpatrick Paul A | 2 |
#6 | Kakkis Emil D | 2 |
#7 | Zecherle Gary N | 2 |
#8 | Chan Wia-Pan | 2 |
#9 | Wendt Dan J | 2 |
#10 | Hendstrand John M | 2 |
Publication | Filing date | Title |
---|---|---|
AU1608701A | Lytic enzymes useful for treating fungal infections | |
WO9958650A1 | Lytic enzymes useful for treating fungal infections | |
AU3006899A | Carbohydrate-modifying enzymes for burn and wound debridement and methods for treatment | |
US6291439B1 | Methods for diagnosing atherosclerosis by measuring endogenous heparin and methods for treating atherosclerosis using heparin |